Commission Implementing Regulation (EU) 2023/1757 of 11 September 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bensulfuron, chlormequat, chlorotoluron, clomazone, daminozide, deltamethrin, eugenol, fludioxonil, flufenacet, flumetralin, fosthiazate, geraniol, MCPA, MCPB, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulfuryl fluoride, tebufenpyrad, thymol, and tritosulfuron-nitrophenolate, sulfuryl fluoride, tebufenpyrad, thymol, and tritosulfuron
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
065/2024
In force in the EEA
Yes
Legal Documents
Commission Implementing Regulation (EU) 2023/1757 of 11 September 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bensulfuron, chlormequat, chlorotoluron, clomazone, daminozide, deltamethrin, eugenol, fludioxonil, flufenacet, flumetralin, fosthiazate, geraniol, MCPA, MCPB, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulfuryl fluoride, tebufenpyrad, thymol, and tritosulfuron-nitrophenolate, sulfuryl fluoride, tebufenpyrad, thymol, and tritosulfuron
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2023/1757 frá 11. september 2023 um breytingu á framkvæmdarreglugerð (ESB) nr. 540/2011 að því er varðar framlengingu á samþykkistímabilum fyrir virku efnin bensúlfúrón, klórmekvat, klórótólúrón, klómasón, damínósíð, deltametrín, evgenól, flúdíoxóníl, flúfenaset, flúmetralín, fosþíasat, geraníól, MCPA, MCPB, própakvisafóp, prósúlfókarb, kvisalófóp-P-etýl, kvisalófóp-P-tefúrýl, natríum-5-nítrógvæjakólat, natríum-o-nítrófenólat, natríum-p-nítrófenólat, súlfúrýlflúoríð, tebúfenpýrað, þýmól og trítósúlfúrón
Durchführungsverordnung (EU) 2023/1757 der Kommission vom 11. September 2023 zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 hinsichtlich der Verlängerung der Laufzeit der Genehmigungen für die Wirkstoffe Bensulfuron, Chlormequat, Chlortoluron, Clomazon, Daminozid, Deltamethrin, Eugenol, Fludioxonil, Flufenacet, Flumetralin, Fosthiazat, Geraniol, MCPA, MCPB, Propaquizafop, Prosulfocarb, Quizalofop-P-ethyl, Quizalofop-P-tefuryl, Natrium-5-nitroguaiacolat, Natrium-o-nitrophenolat, Natrium-p-nitrophenolat, Sulfurylfluorid, Tebufenpyrad, Thymol und Tritosulfuron
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.